As­traZeneca is leav­ing the lob­by­ing group PhRMA, third drug­mak­er to ditch trade group in last five months

As­traZeneca has joined Te­va and Ab­b­Vie in de­part­ing the US drug lob­by group Phar­ma­ceu­ti­cal Re­search and Man­u­fac­tur­ers of Amer­i­ca, say­ing it made the de­ci­sion to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.